The AstraZeneca vaccine and over-65s: We may not have all the data yet, but limiting access could be counterproductive
Older caregivers struggling with extra burdens of home care during COVID-19
1 February 2021Top-speed antibody development
1 February 2021The AstraZeneca vaccine and over-65s: We may not have all the data yet, but limiting access could be counterproductive
Last week, a German vaccine advisory committee recommended the AstraZeneca vaccine only be used in 18-64-year-olds, citing a lack of data on the efficacy of the vaccine in people over 65.
